FDA Clearance Tracker · K240295
InstaStrip Fentanyl Rapid Test (Urine); InstaStrip Fentanyl Dipstick Test (Urine)
Last checked: Nov 19, 2026Latest source record: Mar 28, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Mar 28, 2024
Substantially Equivalent
Time to decision
56 days
Received Feb 1, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K240295
- Device name
- InstaStrip Fentanyl Rapid Test (Urine); InstaStrip Fentanyl Dipstick Test (Urine)
- Applicant
- Instanosis, Inc.
- Applicant location
- King Of Prussia, PA
- Received
- Feb 1, 2024
- Decided
- Mar 28, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Opiates, Over The Counter (NGL)
- Device class
- Class II
- Regulation
- 21 CFR 862.3650
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NGL. The earliest in FDA's data is K082898, decided Dec 19, 2008.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K240295
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Instanosis, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.